2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride

C92H94Br3ClF2N22O17 — CID 157461900

IUPAC2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride
SMILESCC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Oc3cc(C)ncn3)cc12.CC(=O)c1nn(CC(=O)O)c2ccc(Oc3cc(C)ncn3)cc12.CC(=O)c1nn(CC(=O)OC(C)(C)C)c2ccc(O)cc12.CC(=O)c1nn(CC(=O)OC(C)(C)C)c2ccc(Oc3cc(C)ncn3)cc12.Cc1cc(Br)ncn1.Cl.O=C(Nc1cccc(Br)n1)[C@@H]1C[C@@H](F)CN1
InChIInChI=1S/C26H23BrFN7O4.C20H22N4O4.C16H14N4O4.C15H18N2O4.C10H11BrFN3O.C5H5BrN2.ClH/c1-14-8-23(30-13-29-14)39-17-6-7-19-18(10-17)25(15(2)36)33-35(19)12-24(37)34-11-16(28)9-20(34)26(38)32-22-5-3-4-21(27)31-22;1-12-8-17(22-11-21-12)27-14-6-7-16-15(9-14)19(13(2)25)23-24(16)10-18(26)28-20(3,4)5;1-9-5-14(18-8-17-9)24-11-3-4-13-12(6-11)16(10(2)21)19-20(13)7-15(22)23;1-9(18)14-11-7-10(19)5-6-12(11)17(16-14)8-13(20)21-15(2,3)4;11-8-2-1-3-9(14-8)15-10(16)7-4-6(12)5-13-7;1-4-2-5(6)8-3-7-4;/h3-8,10,13,16,20H,9,11-12H2,1-2H3,(H,31,32,38);6-9,11H,10H2,1-5H3;3-6,8H,7H2,1-2H3,(H,22,23);5-7,19H,8H2,1-4H3;1-3,6-7,13H,4-5H2,(H,14,15,16);2-3H,1H3;1H/t16-,20+;;;;6-,7+;;/m1...1../s1
InChIKeyBRPVHQDMWHOKSN-DXTMYDOJSA-N
MW2093.06 g/mol
LogP15.29
Rot. Bonds22

About 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride

2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride (PubChem CID 157461900) has the molecular formula C92H94Br3ClF2N22O17 and a molecular weight of 2093.06 g/mol. Its IUPAC name is 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride.

Molecular Properties

Compound Name2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride
PubChem CID157461900
Molecular FormulaC92H94Br3ClF2N22O17
Molecular Weight2093.06 g/mol
Exact Mass2088.44
IUPAC Name2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride
SMILESCC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Oc3cc(C)ncn3)cc12.CC(=O)c1nn(CC(=O)O)c2ccc(Oc3cc(C)ncn3)cc12.CC(=O)c1nn(CC(=O)OC(C)(C)C)c2ccc(O)cc12.CC(=O)c1nn(CC(=O)OC(C)(C)C)c2ccc(Oc3cc(C)ncn3)cc12.Cc1cc(Br)ncn1.Cl.O=C(Nc1cccc(Br)n1)[C@@H]1C[C@@H](F)CN1
InChIInChI=1S/C26H23BrFN7O4.C20H22N4O4.C16H14N4O4.C15H18N2O4.C10H11BrFN3O.C5H5BrN2.ClH/c1-14-8-23(30-13-29-14)39-17-6-7-19-18(10-17)25(15(2)36)33-35(19)12-24(37)34-11-16(28)9-20(34)26(38)32-22-5-3-4-21(27)31-22;1-12-8-17(22-11-21-12)27-14-6-7-16-15(9-14)19(13(2)25)23-24(16)10-18(26)28-20(3,4)5;1-9-5-14(18-8-17-9)24-11-3-4-13-12(6-11)16(10(2)21)19-20(13)7-15(22)23;1-9(18)14-11-7-10(19)5-6-12(11)17(16-14)8-13(20)21-15(2,3)4;11-8-2-1-3-9(14-8)15-10(16)7-4-6(12)5-13-7;1-4-2-5(6)8-3-7-4;/h3-8,10,13,16,20H,9,11-12H2,1-2H3,(H,31,32,38);6-9,11H,10H2,1-5H3;3-6,8H,7H2,1-2H3,(H,22,23);5-7,19H,8H2,1-4H3;1-3,6-7,13H,4-5H2,(H,14,15,16);2-3H,1H3;1H/t16-,20+;;;;6-,7+;;/m1...1../s1
InChIKeyBRPVHQDMWHOKSN-DXTMYDOJSA-N
XLogP15.29
TPSA496.82 Ų
H-Bond Donors5
H-Bond Acceptors35
Rotatable Bonds22
Heavy Atoms137
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002093.06
LogP ≤ 515.29
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride?
The IUPAC name of 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride (CID 157461900) is 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride.
What is the SMILES notation for 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride?
The canonical SMILES for 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride is CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Oc3cc(C)ncn3)cc12.CC(=O)c1nn(CC(=O)O)c2ccc(Oc3cc(C)ncn3)cc12.CC(=O)c1nn(CC(=O)OC(C)(C)C)c2ccc(O)cc12.CC(=O)c1nn(CC(=O)OC(C)(C)C)c2ccc(Oc3cc(C)ncn3)cc12.Cc1cc(Br)ncn1.Cl.O=C(Nc1cccc(Br)n1)[C@@H]1C[C@@H](F)CN1.
What is the InChIKey of 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride?
The InChIKey is BRPVHQDMWHOKSN-DXTMYDOJSA-N. The full InChI is InChI=1S/C26H23BrFN7O4.C20H22N4O4.C16H14N4O4.C15H18N2O4.C10H11BrFN3O.C5H5BrN2.ClH/c1-14-8-23(30-13-29-14)39-17-6-7-19-18(10-17)25(15(2)36)33-35(19)12-24(37)34-11-16(28)9-20(34)26(38)32-22-5-3-4-21(27)31-22;1-12-8-17(22-11-21-12)27-14-6-7-16-15(9-14)19(13(2)25)23-24(16)10-18(26)28-20(3,4)5;1-9-5-14(18-8-17-9)24-11-3-4-13-12(6-11)16(10(2)21)19-20(13)7-15(22)23;1-9(18)14-11-7-10(19)5-6-12(11)17(16-14)8-13(20)21-15(2,3)4;11-8-2-1-3-9(14-8)15-10(16)7-4-6(12)5-13-7;1-4-2-5(6)8-3-7-4;/h3-8,10,13,16,20H,9,11-12H2,1-2H3,(H,31,32,38);6-9,11H,10H2,1-5H3;3-6,8H,7H2,1-2H3,(H,22,23);5-7,19H,8H2,1-4H3;1-3,6-7,13H,4-5H2,(H,14,15,16);2-3H,1H3;1H/t16-,20+;;;;6-,7+;;/m1...1../s1.
What are the key properties of 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride?
2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride has a molecular weight of 2093.06 g/mol, XLogP of 15.29, 22 rotatable bonds, 5 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetic acid;(2S,4R)-1-[2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;4-bromo-6-methylpyrimidine;(2S,4R)-N-(6-bromo-2-pyridinyl)-4-fluoropyrrolidine-2-carboxamide;tert-butyl 2-(3-acetyl-5-hydroxyindazol-1-yl)acetate;tert-butyl 2-[3-acetyl-5-(6-methylpyrimidin-4-yl)oxyindazol-1-yl]acetate;hydrochloride is sourced from PubChem (CID 157461900), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).